GlassScriptPhysician profile
Paul Augustine Trapasso
NPI 1679608566
$4,767.30
in general payments reported to CMS, 2019-2025
19 companies · $1,423 in 2025
The $1,423 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $934 · 2022: $86.27 · 2023: $293 · 2024: $2,032 · 2025: $1,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,275 · Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,275.03 |
| Food and Beverage | $1,471.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,402.16 | 2024 | Stratafix |
| Arthrex, INC. | $632.40 | 2025 | |
| Gotham Surgical Solutions & Devices, INC. | $601.83 | 2025 | |
| Stryker Corporation | $529.33 | 2021-2024 | Mako, Accolade |
| Kerecis Limited | $300.88 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Molnlycke Health Care US, LLC | $217.48 | 2023-2025 | Mepilex Border Post-Op Ag, Avance, Mepilex Border Ag |
| Axogen | $166.28 | 2021 | |
| Depuy Synthes Sales INC. | $150.78 | 2021 | |
| Heron Therapeutics, INC. | $129.89 | 2021-2023 | Zynrelef |
| Spine Wave, INC. | $121.87 | 2021 | |
| Globus Medical, INC. | $120.27 | 2021 | |
| Biocomposites INC | $105.00 | 2024 | |
| Bone Support INC. | $103.96 | 2024 | Ceramentbone Void Filler, Cerament G |
| Orthofix Medical, INC. | $43.57 | 2023 | Spinal-Stim, Spinal-Stim |
| Ethicon US, LLC | $33.72 | 2024 | Ethicon, Vistaseal, Stratafix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $30.39 | 2022 | |
| Zimmer Biomet Holdings, INC. | $28.27 | 2025 | Avenir |
| Nalu Medical, INC. | $24.99 | 2025 | Nalu Neurostimulation System |
| Solventum Corporation | $24.23 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Trapasso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.